Shelly C. Lu MD

Shelly Lu, MD, has been working in the fields of S-adenosylmethionine and glutathione metabolism for more than 20 years and has received uninterrupted funding from the National Institutes of Health (NIH) since 1992. Lu currently has five active NIH-funded research programs that investigate molecular mechanisms of fatty liver, liver injury, liver cancer, and colon cancer. Many of the research projects have translational applications, such as identifying biomarkers that can differentiate simple fatty liver from those with more a severe form called nonalcoholic steatohepatitis, identifying biomarkers that might predict prognosis and response to chemotherapy in colon cancer, and examining agents that are effective in the prevention and treatment of liver and colon cancer.